Potentiation of antimetastatic activity of pentoxifylline in B16F10 and B16F1 melanoma cells through inhibition of glutathione content

Cancer Biotherapy and Radiopharmaceuticals

Volumn 18, Issue 4, 2003, Pages 559-564

  Shukla, Vivek ^a   Gude, Rajiv P ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

B16F10 and B16F1 cell lines; Free radicals; GSH; GST; LPOs; Metastasis; Pentoxifylline (PTX); PUFAs; TBARS

Indexed keywords

GLUTATHIONE; GLUTATHIONE TRANSFERASE; PENTOXIFYLLINE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG MECHANISM; ENZYME ACTIVITY; LIPID PEROXIDATION; MELANOMA CELL; METASTASIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; UPREGULATION;

EID: 0041335500     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/108497803322287637     Document Type: Article

References (29)

1. Tew KD. Glutathione- associated enzymes in anticancer drug resistance. Cancer Res 1994;54:191.
2. Brockmoller J, Cascorbi I, Henning S, Meisel C, Roots I. Molecular genetics of cancer susceptibility. Pharmacology 2000;61:212.
3. Marnett LJ. Oxyradicals and DNA damage. Carcinogenesis 2000;21:361.
4. Ratan RR, Murphy TH, Baraban JM. Oxidative stress induces apoptosis in embryonic cortical neurons. J Neurochem 62:376.
5. Morrow CS, Cowan KH: Glutathione-S-transferase and drug resistance. Cancer Cells 1990;2:15.
6. Petersen ES, Kelley EE, Modest E, Burns CP. Membrane lipid modification and sensitivity cells to the thioether lipid analogue BM41, 140. Cancer Res 1992;42:6263.
7. Shao Y, Pardini L, Pardini RS. Dietary menhaden oil enhances mitomycin C antitumor activity toward human mammary carcinoma MX-1. Lipids 1995;30:1035.
8. Chajes V, Sattler W, Stranl A, Kostner G. Influence of n-3 fatty acids on the growth of human breast cancer cells in vitro: A relationship to peroxides and vitamin E. Breast Cancer Res Treat 1996;34:199.
9. Gonzalez MJ, Schemmel RA, Gray JI, Dugan L, Welsch CW. Dietary fish oil inhibits human breast carcinoma growth: A function of increased lipid peroxidation. Lipids 1993;28:827.
10. Sellin S, Holmquist B, Mannervik B, Valluee BL. Oxidation and reduction of 4-hydroxyalkenals catalysed by isozymes of human alcohol dehydrogenase. Biochemistry 1991;30:2514.
11. Somalaska CP, Winfield EA. Pentoxifylline. J Ad Acad Dermatol 1994;30:603.
12. Rao KK, Cohen HJ, Curie MS. Actin depolymerization and inhibition of capping induced by pentoxifylline in human lymphocytes and neutrophils. J Cell Physiol 1988;137:577.
13. Newton JA, Ashwood ER, Yang KD, Augustine NH, Hill HR. Effect of pentoxifylline on developmental changes in neutrophil cell surface mobility and membrane fluidity. J Cell Physiol 1989;140:427.
14. Lissoni P, Aradizzoia A, Barni S, Pittalis S, Rosini F, Porta A, Tancini G. Characterization of cancer-related disseminated intravascular coagulation in relation to tumor necrosis factor alpha blood concentrations: Possible therapeutic role of pentoxifylline. Tumori 1996;82:78.
15. Gude RP, Ingle ID, Rao SGA. Inhibition of lung horning of B16F10 by pentoxifylline, a microfilament depolymerizing agent. Cancer Lett 1996;106:171.
16. Rajiv P Gude, M Mercedes Binda, Hector Lopez Presas, Andres JP, Klein-Szanto R, Daniel Bonfil. Studies on the mechanisms responsible for inhibition of experimental metastasis of B16F10 murine melanoma by pentoxifylline. J Biomed Sci 1998;6:133.
17. Fidler IJ. Selection of successive tumor line for metastasis. Nature New Biol 1973;242:148.
18. Beutler E. in Red Cell Metabolism (Beutler E, Ed.) 3rd Ed., Grunne and Stratton, New York, 1984; pp. 77.
19. Habig WH, Jakoby WB. Assays for differentiation of glutathione-S-transferase. Meth Enzymol 1981;77:398.
20. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues of thiobarbituric acid action. Anal Biochem 1979;95:351.
21. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Bio Chem 1951;193:265.
22. Gude P Rajiv, Binda Mecredes M, Boquete L, Aleandra, Bonfil Daniel R. Inhibition of endothelial cell proliferation and tumor-induced angiogenesis by pentoxifylline. J Cancer Res Clin Oncol 2001;127:625.
23. Arrick A Bradley, Nathan F Carl. Glutathione metabolism as a determinant of therapeutic efficacy. A review. Cancer Res 1984;44:4424.
24. Nelson S David, Cox M Michael. Lehninger principles of biochemistry. Biosignalling 2000;3:454.
25. Corretero J, Obrador E, Anasagasti JJ, Martin F, Vidal-Vanaclocha JM, Estrela. Growth associated changes in glutathione content correlate with liver metastatic activity of B16 melanoma cells. Clin Exp Metastasis 1999;17:567.
26. Chakraborty AK, Ueda M, Mishima Y, Ischiashi M. Intracellular glutathione and its metabolizing enzyme activities in a metastatic variant melanoma cell line. Melanoma Res 1992;2:315.
27. Chang M, Rao MK, Reddanna P, Li CH, Tu CP, Corey EJ, Reddy CC. Specificity of the glutathione-S-transferase in the conversion of leukotriene A4 to leukotriene C4. Arch Biochem Biophys 1987;259:536.
28. Rosignoli P, Fabianai R, Bartolomeo De A, Spinozzi F, Agea E, Pelli AM, Morozzi G. Protective activity of butyrate on hydrogen peroxide-induced DNA damage in isolated human colonocytes and HT29 tumor cells. Carcinogenesis 2001;22:1675.
29. Germain E, Chajes V, Cognault S, Lhuillery C, Bougnoux: Enhancement of doxorubicin by polyunsaturated fatty acids in the human breast tumor cell line MDA-MB-231: Relationship to lipid peroxidation. Int J Cancer 1998;75:578.